On September 22, the U.S. President Donald Trump publicly stated that “using acetaminophen (commonly known by the brand Tylenol) during pregnancy may be linked to an increased risk of autism.” His remarks have drawn significant attention from both the medical community and investors, once again putting acetaminophen safety in the spotlight.
Read more
